Expanding Access to Naloxone in the United States

Journal of Medical Toxicology

Volumn 10, Issue 4, 2014, Pages 431-434

  Doyon, Suzanne ^a   Aks, Steven E ^b   Schaeffer, Scott ^c  

^a American Academy of Clinical Toxicology   (United States)

^b American College of Medical Toxicology   (United States)

^c American Association of Poison Control Centers   (United States)

Author keywords

Bystander naloxone; Naloxone; Opiate; Opioid; Overdose

Indexed keywords

BENZODIAZEPINE; FLUMAZENIL; NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ARTICLE; DELIRIUM; DELIRIUM TREMENS; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; HUMAN; SUPPLY AND DISTRIBUTION; UNITED STATES;

ANALGESICS, OPIOID; DRUG OVERDOSE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; UNITED STATES;

EID: 84916241216     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-014-0432-1     Document Type: Article

References (45)

1. Warner M, Hui L, Makuc DL, Anderson RN et al (2011) Drug poisoning deaths in the United States, 1980–2008. NCHS data brief no 81. National Center for Health Statistics, Hyattsville
2. Wheeler E, Davidson PJ, Jones S et al (2012) Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR 61(06):101–5
3. Jones CM, Mack KA, Paulozzi LJ (2013) Pharmaceutical overdose deaths, United Sates 2010. JAMA 309:657–9
4. Heroin-related deaths in the US. Blog for the National Center for Health Statistics http://nchstats.com/2014/02/05/heroin-related-deaths-in-the-us/. Accessed April 11 2014.
5. Maryland Department of Health and Mental Hygiene http://dhmh.maryland.gov/newsroom1/Pages/DHMH-Warns-of-Potent-and-Deadly-Drug-Combination.aspx Accessed April 2014.
6. Ogilvie L, Stanley C, Lewis L et al (2013) Notes from the field: acetyl fentanyl overdose fatalities-Rhode Island March–May 2013. MMWR 62(34):703–4
7. Philadelphia Department of Public Health. Overdoses from tainted opioids recommendations for management. Health Advisory 2014; https://hip.phila.gov/xv/Portals/0/HIP/Health_Alerts/2014/PDPH-HAN_Advisory_2_TaintedOpioidOverdoses_012814.pdf Accessed April 2014.
8. Centers for Disease Control and Prevention (2012) CDC Grand Rounds: prescription drug overdoses—a U.S. epidemic. MMWR 61(01):10–3
9. Pattinson KT (2008) Opioids and the control of respiration. Br J Anaesth 100(6):747–58
10. Lalley PM (2008) Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol 164:160–7
11. Lalley PM (2003) Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: evidence for involvement in certain types of ventilatory disturbances. Am J Physiol Regul Integr Comp Physiol 285:R1287–304
12. Wermeling DP (2013) A response to the opioid overdose epidemic: naloxone nasal spray. Drug Deliv and Transl Res 3:63–74
13. Wolfe TR, Braude DA (2010) Intranasal medication delivery for children: a brief review and update. Pediatrics 126:532–7
14. Sporer KA, Kral AH (2007) Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 49(2):172–7
15. Piper TM, Stancliff S, Rudenstine S et al (2008) Evaluation of a naloxone distribution administration program in New York City. Subs Abuse Misuse 43:858–70
16. Enteen L, Bauer J, McLean R et al (2010) Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 87(6):931–41
17. Dietze P, Cantwell K, Burgess S (2002) Bystander resuscitation attempts at heroin overdose: does it improve outcomes? Drug Alcohol Depend 67:213–8
18. Doe-Simkins M, Quinn E, Xuan Z et al (2014) Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective study. BMC Public Health 14(297):1–11
19. Loimer N, Hofmann P, Choudhry HR (1992) Nasal administration of naloxone for detection of opiate dependence. J Psychiatr Res 26(1):39–43
20. Loimer N, Hofmann P, Choudhry HR (1994) Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict 29(6):819–27
21. Kelly AM, Koutsogiannis Z (2002) Intranasal naloxone for life-threatening opioid overdose. Emerg Med J 19(4):375
22. Seal KH, Thawley R, Gee L et al (2005) Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 82:303–11
23. Maxwell S, Bigg D, Stanczykiewicz K et al (2006) Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 25(3):89–96
24. Tobin KA, Sherman SG, Beilenson P et al (2009) Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 20:131–6
25. Doe-Simkins M, Walley AY, Epstein A et al (2009) Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 99(5):788–90
26. Benett AS, Bell A, Tomedi L et al (2011) Characteristics of an overdose prevention response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health 88(6):1020–30
27. Walley A, Xuan Z, Hackman HH et al (2013) Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 346:f174, 1:12
28. Walley AY, Doe-Simkins M, Quinn E et al (2013) Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat 44:241–7
29. Wagner KD, Valente TW, Casanova M et al (2010) Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 21(3):186–93
30. Su A, Brason FW, Sanford C et al (2011) Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med 12:S77–85
31. Buajordet I, Naess AC, Jacobsen D et al (2004) Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Euro J Emerg Med 11:19–23
32. Sporer KA (1999) Acute heroin overdose. Ann Intern Med 130(7):584–90
33. Merigian KS (1993) Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporarily related to naloxone administration. Am J Emerg Med 11:96–7
34. Osterwalder JJ (1996) Naloxone—for intoxications with intravenous heroin and heroin mixtures—harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 34(4):409–16
35. Kim D, Irwin KS, Koshnood K (2009) Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health 99(3):402–7
36. Wampler DA, Molina K, McManus J, Laws P, Manifold A (2011) No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care 15:320–4
37. Vilke GM, Sloane C, Smith AM et al (2003) Assessment for deaths in out-of-hospital heroin overdoses patients treated with naloxone who refuse transport. Acad Emerg Med 10(8):893–6
38. Leece P, Orkin A (2013) Opioid overdose fatality prevention (letter). JAMA 309(9):873–4
39. Morris J (2000) Defining the precautionary principle. In: rethinking risk and the precautionary principle. New York: Butterworth-Heinemann, 1–21.
40. Goklany IM (2002) From precautionary principle to risk-risk analysis. Nat Biotechnol 20:1075
41. Belestky L, Rich JD, Walley AY (2013) Opioid overdose fatality prevention (reply to letter). JAMA 309(9):874
42. Strang J, Powis B, Best D et al (1999) Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction 94:199–204
43. Dettmer K, Saunders B, Strang J (2001) Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ 322(7291):895–6
44. Tracy M, Piper TM, Ompad D et al (2005) Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend 79:181–90
45. Lagu T, Anderson BJ, Stein M (2006) Overdoses among friends: drug users-are willing to administer naloxone to others. J Subst Abuse Treat 30:129–33